Researchers at NYU College of Dentistry’s Pain Research Center screened 27 million compounds and identified one that reversed four types of chronic pain in animal studies. The small molecule outperformed gabapentin without bothersome side effects, making it a potential new treatment for pain.
Read more here.
Did you enjoy this article?
Subscribe to the PAINWeek Newsletter
and get our latest articles and more direct to your inbox